Shilpa Biologicals signs co-development deal with Finland's Orion

Shilpa Biologicals signs co-development deal with Finland's Orion Shilpa Biologicals Pvt Ltd, a wholly owned subsidiary of Shilpa Medicare, has entered into a co-development and supply agreement with Orion Corporation of Finland. The partnership focuses on advancing and supplying pharmaceutical products. This strategic move enhances Shilpa's global footprint and R&D capabilities.

📊 STOCKS: SHILPAMED | 🏢 SECTOR: Pharma | #MEDIUMIMPACT #pharma